Key points
Affiliates
Jaime Raymond [1], Paul Mehta [1], Ted Larson [1], Erik P. Pioro [2], D. Kevin Horton [1]
- Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention
- Section of ALS and Related Disorders, The Cleveland Clinic
Summary
Estrogen has suspected neuroprotective properties. This investigation seeks to understand how early onset menopause and coinciding drops in estrogen production relay risk of ALS. This examination reported a positive association between receiving an ALS diagnosis before age 60 for women who entered menopause before age 50 when compared to women who reported entering menopause after age 50.
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.